Keyphrases
Israel
96%
Bloodstream Infection
74%
Carbapenem-resistant Acinetobacter Baumannii
63%
Escherichia Coli
51%
Risk Factors
42%
Neonatal Intensive Care Unit
42%
Bacteremia
35%
Hospital Admission
31%
Carbapenem-resistant Enterobacteriaceae
30%
Antimicrobial Resistance
30%
Carbapenem Resistance
26%
Hospital-onset
26%
Peripheral Blood
24%
Acinetobacter Baumannii (A. baumannii)
24%
Pseudomonas Aeruginosa (P. aeruginosa)
23%
Erythrocytes
22%
Fecal Carriage
22%
Carbapenemases
22%
Hospitalized Patients
21%
Extended-spectrum-lactamase
21%
Vancomycin-resistant Enterococci
21%
KPC-2
21%
National Cohort Study
21%
Active Surveillance
21%
Clostridium Difficile Infection
20%
Dextran Sulfate Sodium
20%
Red Blood Cell Aggregation
20%
Clinical Characteristics
20%
OXA-48
20%
Population-based Study
20%
Tel Aviv
19%
Sentinel
19%
Producing Escherichia Coli
18%
Klebsiella Pneumoniae (K. pneumoniae)
16%
Israeli
16%
Plasmid
16%
Enterobacteriaceae
16%
Odds Ratio
16%
1-year Mortality
15%
Lipoproteins
15%
Fibrinogen
15%
Colistin
15%
Multidrug-resistant
15%
LDL Apheresis
14%
Cholesterol
14%
Infection Control
14%
Fourier Transform Infrared Spectroscopy (FT-IR)
14%
Confidence Interval
14%
Comorbidity
13%
Infection Rate
13%
Medicine and Dentistry
Bloodstream Infection
58%
Carbapenem
57%
Acinetobacter Baumannii
53%
Escherichia coli
42%
Infection
41%
Antibiotic Resistance
33%
Carbapenem-Resistant Enterobacteriaceae
30%
Neonatal Intensive Care Unit
30%
Penicillinase
23%
Infection Control
23%
Enterococcus faecium
22%
Vancomycin Resistant Enterococcus
21%
Carbapenemase
21%
Pathogen
20%
Intensive Care Unit
19%
Prevalence
14%
Extended Spectrum Beta Lactamase
13%
Intensive Care
13%
Wound
12%
Hysterectomy
12%
Enterobacteriaceae
12%
Sepsis
12%
Beta-Lactamase
12%
Cohort Effect
12%
Newborn Intensive Care
12%
Subacute Care
12%
Odds Ratio
11%
Cohort Analysis
11%
Risk Perception
10%
Extended Spectrum Beta Lactamase Producing Klebsiella Pneumoniae
10%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
10%
Atherosclerosis
10%
Laboratory Diagnosis
10%
Effusion
10%
Clostridium Difficile Infection
10%
Meningitis
10%
LDL Apheresis
10%
Heat Tolerance
10%
Genome Sequencing
10%
Ribosome DNA
10%
Peripheral Vascular Disease
10%
Thorax Radiography
10%
Congenital Tuberculosis
10%
Wound Infection
10%
Peptoclostridium difficile
10%
DNA Sequence
10%
Endoscope
10%
Patient Isolation
10%
COVID-19
10%
Adenosine Triphosphate
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Escherichia coli
48%
Acinetobacter Baumannii
44%
Infection
42%
Antimicrobial Resistance
40%
Carbapenem
36%
Pseudomonas aeruginosa
25%
Penicillinase
23%
Extended Spectrum Beta Lactamase
20%
Carbapenemase
20%
Enterobacteriaceae
13%
Antimicrobial Therapy
13%
Diseases
13%
Adverse Outcome
12%
Lactam
12%
Klebsiella
11%
Cohort Study
11%
Hypercholesterolemia
11%
Prevalence
11%
Syndrome
11%
Comorbidity
11%
Diclofenac
10%
Low Density Lipoprotein
10%
Clostridium Difficile Infection
10%
Lipoprotein
10%
Atherosclerosis
10%
Diarrhea
10%
Quinolone Derivative
10%
Rhabdomyolysis
10%
Peptoclostridium difficile
10%
Fibrinogen
10%
Fourier Transform Infrared Spectroscopy
10%
Wound Infection
10%
Cerivastatin
10%
Dextran Sulfate
10%
Homocysteine
10%
Coronavirinae
10%
Enterobacter
10%
Bacterial Infection
10%
2009 H1N1 Influenza
10%
Gram Negative Sepsis
10%
Lung Tuberculosis
10%
Microorganism
10%
Antibiotics
9%
Infectious Agent
8%
Acinetobacter Infection
6%
Enterococcus faecalis
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Septic Shock
5%
Atherogenesis
5%
